Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia

NJ Short, H Kantarjian - The Lancet Haematology, 2022 - thelancet.com
The outcomes of older patients with acute myeloid leukaemia are inferior to their younger
counterparts, because, in part, of a more aggressive disease biology and poorer tolerance of …

Understanding the role of vitamin A and its precursors in the immune system

M Gürbüz, Ş Aktaç - Nutrition Clinique et Métabolisme, 2022 - Elsevier
Vitamin A is the first defined vitamin and is also known as an anti-inflammatory micronutrient.
Although the primary biological function is preservation of epithelial tissue integrity, vision …

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

G Oñate, A Bataller, A Garrido, M Hoyos… - Blood …, 2022 - ashpublications.org
The negative prognostic impact of internal tandem duplication of FLT3 (FLT3-ITD) in patients
with acute myeloid leukemia with mutated NPM1 (AML-NPM1) is restricted to those with a …

Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review

Q Hao, F Foroutan, MA Han, T Devji, FK Nampo… - Plos one, 2022 - journals.plos.org
Background and objective The prognostic value of age and other non-hematological factors
in predicting outcomes in older patients with newly diagnosed acute myeloid leukemia …

Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells

JJ Gleba, D Kłopotowska, J Banach, KA Mielko… - International Journal of …, 2022 - mdpi.com
Non-coding micro-RNA (miRNAs) regulate the protein expression responsible for cell
growth and proliferation. miRNAs also play a role in a cancer cells' response to drug …

[HTML][HTML] RXRA DT448/9PP generates a dominant active variant capable of inducing maturation in acute myeloid leukemia cells

O Di Martino, MA Ferris, G Hadwiger, S Sarkar… - …, 2022 - ncbi.nlm.nih.gov
RARA and RXRA contribute to myeloid maturation in both mice and humans, and deletion of
Rxra and Rxrb augments leukemic growth in mice. While defining the domains of RXRA that …

[HTML][HTML] Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis

Z Wang, W Gao, H Zhao, C Yin, Z Wang, L Tian… - Acta …, 2022 - karger.com
Introduction: The overall outcome of patients with refractory AML (rAML) remains poor.
Though allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered as the …

Validating the knowledge bank approach for personalized prediction of survival in acute myeloid leukemia: a reproducibility study

Y Xu, U Mansmann - Human Genetics, 2022 - Springer
Reproducibility is not only essential for the integrity of scientific research but is also a
prerequisite for model validation and refinement for the future application of predictive …

Mitigating Myeloid-Driven Pathways of Immune Suppression to Enhance Cancer Immunotherapy Efficacy

SH Colligan - 2022 - search.proquest.com
The discovery and application of immune checkpoint inhibitors (ICIs) has revolutionized the
therapeutic landscape in oncology. This discovery culminated from the elegant body-of-work …

[引用][C] Inzidenz von ASXL1 Mutationen und deren prognostische Bedeutung bei akuter myeloischer Leukämie von über 60-jährigen Patienten

B Ullmann - Dissertation, Ulm, Universität Ulm …